—
C+
C+ The full Closelook — membership. Open the C+ overview

Almirall S.A. (ALM.MC) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Almirall S.A. ranks 8 of 12 in its cohort on the Closelook composite (52/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ALM.MC Almirall S.A. 52 25 44 67 warn 23.2%
ALKS Alkermes Plc 53 75 51 23 info 16.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 53 85 56 43 ok 5.1%
BHC.TO Bausch Health Companies Inc 53 49 69 84 info 28.5%
FAGR.BR Fagron NV 51 40 53 61 info 12.3%
TAK Takeda Pharmaceutical Co Ltd ADR 50 70 37 81 ok 0.3%
APTX.TO Apotex Health Corp 48 63 55 50 — —
GRF.MC Grifols S.A. 48 47 41 81 warn 24%
BION.SW BB Biotech AG 74 73 95 81 info 8.4%
ARGX.BR Argen-X 64 78 73 28 ok 6.2%
ARGX argenx NV ADR 64 78 72 27 ok 7.2%
LLY Eli Lilly and Company 64 68 90 29 watch 10.8%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Almirall S.A.'s peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Alkermes Plc (ALKS), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Bausch Health Companies Inc (BHC.TO), Fagron NV (FAGR.BR), Takeda Pharmaceutical Co Ltd ADR (TAK), Apotex Health Corp (APTX.TO), Grifols S.A. (GRF.MC), BB Biotech AG (BION.SW) and others.

How does ALM.MC score against its peers?

Almirall S.A.'s composite reads 52/100, ranking 8 of 12 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.